Clinical Trials in Houston

Showing 8161-8180 of 13,620 trials

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

NCT01993186

The primary objectives of the study are to evaluate the efficacy of UX007 compared to placebo as measured by the reduction from randomization to Week 8 in frequency of seizures and to evaluate the safety of UX007 via adverse event (AE) rates, laboratory values, and electrocardiogram (ECG).

Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Ultragenyx Pharmaceutical Inc36 participantsStarted Feb 2014

Aurora, Colorado, United States • Miami, Florida, United States • Orlando, Florida, United States +11 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

NCT01172938

The purpose of this study is to determine whether apremilast is safe and effective in the treatment of patients with psoriatic arthritis, specifically in improving signs and symptoms of psoriatic arthritis (tender and swollen joints, pain, physical function) in treated patients.

Psoriatic Arthritis

Amgen504 participantsStarted Jun 2010

Birmingham, Alabama, United States • Phoenix, Arizona, United States • La Jolla, California, United States +89 more locations

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

Find Trials by Condition in Houston

Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine

Study of Vemurafenib, Carboplatin, and Paclitaxel

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

Screening for Familial Colorectal Cancer (CRC) Patients

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

GSK2982772 Study in Subjects With Ulcerative Colitis

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD